RADIOACTIVE IMMUNOREAGENT OF THE DIRECTED EFFECT, A COMPOSITION FOR OBTAINING AN IMAGE OF MALIGNANT NEOPLASM IN BODY, A METHOD OF OBTAINING AN IMAGE AND A CHELATING AGENT Russian patent published in 1998 - IPC

Abstract RU 2122431 C1

FIELD: medicine, radiodiagnosis. SUBSTANCE: invention relates to radioactive immunoreagent exhibiting the directed effect that is a conjugate of a chelating agent and immunoreactive group labeled with radioactive metal ion. Ion of radioactive metal has an atomic number from 21 to 84. Immunoreactive group is an antibody, oligonucleotide or polypeptide. Chelating agent is a derivative of tripyridine. Invention gives the total formula of a chelating agent used. A composition for obtaining an image of malignant neoplasm in body containing a contrasting radioactive agent of the above indicated composition at effective amount and pharmaceutically acceptable diluting agent is described also. Invention relates to also a method of obtaining an image of malignant neoplasm. Method is carried out by administration to patient a composition containing radioactive label that involves a chelate at effective amount. Radiation intensity produced by radioactive label is measured for time that is necessary for antibody accumulation on neoplasm site. Radiation intensity is determined using the special device for photoscanning. Invention gives also a chelating agent that is a component of immunoreactive of the directed effect that is a tripyridine derivative. Proposed immunoreagents do not metabolize and harmful dispersing, show less radiotoxicity as compared with yttrium-containing radioactive immunoreagents obtained with other chelating agents. EFFECT: improved method of an image obtaining, improved quality of composition. 12 cl, 7 dwg, 20 ex

Similar patents RU2122431C1

Title Year Author Number
RADIOACTIVE LABELING SET AND BINDING ANALYSIS 2000
  • Chinn Pol
  • Morena Ronal'D
  • Labarr Majkl
  • Leonard Dzhon Eh.
RU2251110C2
METHOD OF DETERMINATION OF GLYCOSYLATED HEMOGLOBIN IN THE PRESENCE OF NONGLYCOSYLATED HEMOGLOBIN, ANALYTICAL TEST KIT 1990
  • Ehrling Sundrekhagen[No]
RU2111494C1
METHOD OF ASSAY OF HOMOCYSTEINE IN SAMPLE AND A SET FOR ITS REALIZATION 1993
  • Ehrling Sundrekhagen
RU2121001C1
COMPLEXES OF METALS WITH BICYCLOPOLYAZAMACROCYCLE, METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION USED FOR TREATMENT OF PATIENTS WITH CANCER 1992
  • Gehrri E.Kifer
  • Dzhejm Sajmon
RU2118325C1
COMPOSITION CONTAINING A BUFFER 2017
  • Funase, Yuichi
  • Kurokawa, Masahiro
RU2757768C2
NOVEL RADIOIMMUNOCONJUGATES AND THEIR APPLICATIONS 2011
  • Larsen Roj Kh.
  • Dakhle Jostejn
  • Bruland Ehjuvind S.
RU2560587C9
RADIOPHARMACEUTICAL SOLUTIONS WITH PREFERRED PROPERTIES 2016
  • Larsen, Roy, Hartvig
RU2741794C2
RADIOTHERAPEUTIC PARTICLES AND SUSPENSIONS 2016
  • Westrom, Sara
  • Larsen, Roy, Hartvig
RU2770073C2
COMPOUND FOR DIAGNOSING TUMOURS EXPRESSING PSMA AND COMPOSITION BASED THEREON 2019
  • Machulkin Aleksej Eduardovich
  • Mazhuga Aleksandr Georgievich
  • Ber Anton Petrovich
  • Petrov Stanislav Aleksandrovich
  • Ivanenkov Yan Andreevich
  • Skvortsov Dmitrij Aleksandrovich
  • Beloglazkina Elena Kimovna
  • Egorova Bajirta Vladimirovna
  • Kalmykova Taisiya Petrovna
RU2730507C1
COMPLEX CONTAINING A PSMA-TARGETING COMPOUND BOUND TO A LEAD OR THORIUM RADIONUCLIDE 2018
  • Larsen, Roy Hartvig
RU2795398C2

RU 2 122 431 C1

Authors

Dzhon L.Touner

Dehvid A.Khilborn

Brjus Dzh.Mjurrej

Timoti Z.Khaussejn

Robert A.Snou

Asis K.Sakha

Richard Filion

Klajd V.Shirman

Chandra Shakh

Dates

1998-11-27Published

1992-05-07Filed